Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114344

Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

B L Gruber, M J Marchese, K Suzuki, L B Schwartz, Y Okada, H Nagase, and N S Ramamurthy

Division of Allergy, Rheumatology and Clinical Immunology, Veterans Administration, Northport, New York 11768.

Find articles by Gruber, B. in: PubMed | Google Scholar

Division of Allergy, Rheumatology and Clinical Immunology, Veterans Administration, Northport, New York 11768.

Find articles by Marchese, M. in: PubMed | Google Scholar

Division of Allergy, Rheumatology and Clinical Immunology, Veterans Administration, Northport, New York 11768.

Find articles by Suzuki, K. in: PubMed | Google Scholar

Division of Allergy, Rheumatology and Clinical Immunology, Veterans Administration, Northport, New York 11768.

Find articles by Schwartz, L. in: PubMed | Google Scholar

Division of Allergy, Rheumatology and Clinical Immunology, Veterans Administration, Northport, New York 11768.

Find articles by Okada, Y. in: PubMed | Google Scholar

Division of Allergy, Rheumatology and Clinical Immunology, Veterans Administration, Northport, New York 11768.

Find articles by Nagase, H. in: PubMed | Google Scholar

Division of Allergy, Rheumatology and Clinical Immunology, Veterans Administration, Northport, New York 11768.

Find articles by Ramamurthy, N. in: PubMed | Google Scholar

Published November 1, 1989 - More info

Published in Volume 84, Issue 5 on November 1, 1989
J Clin Invest. 1989;84(5):1657–1662. https://doi.org/10.1172/JCI114344.
© 1989 The American Society for Clinical Investigation
Published November 1, 1989 - Version history
View PDF
Abstract

Mast cells have been implicated in the pathogenesis of the matrix degradation observed in the cartilaginous and osseous structures of the rheumatoid joint. We previously reported that human mast cell tryptase, a 134-kD granule-associated neutral protease, is present in rheumatoid synovium and can activate collagenase in crude culture medium in vitro. the present study attempts to depict the precise mechanism of this activation. To express full activation of latent collagenase, matrix metalloproteinase 3 (MMP-3) or stromelysin, can be activated by tryptase in a time and dose-dependent manner. Tryptase was not capable of generating active collagenase in the crude media from cultured rheumatoid synoviocytes depleted of proMMP-3 by immunoadsorption. In addition, the function of the tissue inhibitor of metalloproteinases (TIMP) was not altered by tryptase, and SDS-PAGE analysis revealed no degradation of TIMP by tryptase. The tryptase dependent activation of synoviocyte procollagenase thereby appears to be entirely dependent upon its ability to activate proMMP-3.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1657
page 1657
icon of scanned page 1658
page 1658
icon of scanned page 1659
page 1659
icon of scanned page 1660
page 1660
icon of scanned page 1661
page 1661
icon of scanned page 1662
page 1662
Version history
  • Version 1 (November 1, 1989): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts